Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Dr. Owen Witte, a pioneer in human leukemias and immune disorders, received the AACR G.H.A. Clowes Memorial Award for his groundbreaking work on tyrosine kinases as drug targets. His discoveries have led to multiple approved targeted therapies, transforming patient outcomes.
A third of breast cancer patients report strong desire for genetic testing but many do not receive relevant discussions with healthcare professionals. This study highlights the unmet need for addressing genetic risk in these patients.
Therapeutic anti-cancer vaccines have been associated with a statistically significant increase in patient survival, but rarely have a noticeable effect on tumor growth. The study suggests that overall survival, rather than progression-free survival, should be the gold standard for evaluating cancer vaccine efficacy.
Breast cancer cells' growth is inhibited by a combination of estradiol and tumor necrosis factor alpha, improving clinical outcomes for some subtypes. The altered gene expression patterns can be used as biomarkers to determine risk and therapy response.
Patients with stage IV cancer prioritize pain management, home deaths, and quality of healthcare over life extension, while caregivers are willing to pay more for these services. The study suggests that patients' preferences should be directly elicited during treatment decision-making.
A clinical trial is enrolling children and adults with graft-versus-host-disease using their own immune cells to target inflammation and reduce organ damage. The personalized cells are derived from the patient's own bone marrow, making them more likely to be effective.
A new review emphasizes the need to decipher immune response dynamics to enhance cancer immunotherapy. Researchers suggest developing combination therapies and biomarker panels to increase treatment impact, as single biomarkers are unlikely to predict patient responses.
A Cancer Research UK review found that older people, women, and less affluent individuals are at a higher risk of emergency cancer diagnoses. The study also revealed that emergency-diagnosed cancers tend to have poorer survival rates compared to those diagnosed through other routes.
A new study found that patients with lower vitamin D levels before treatment for follicular lymphoma have a worse prognosis and are more likely to succumb to the disease or face relapse earlier. Vitamin D deficiency may represent a modifiable risk factor for this type of cancer.
Dr. Lewis C. Cantley is being recognized for his groundbreaking work in discovering the phosphoinositide 3-kinase (PI3K) enzyme and elucidating its role in cancer development. His research has led to the development of personalized cancer therapies targeting the PI3K signaling pathway.
Dr. Lucile Adams-Campbell is recognized for her scientific work in cancer epidemiology and health disparities, as well as her dedication to mentoring minority researchers. She will receive the AACR-MICR Jane Cooke Wright Lectureship at the AACR Annual Meeting 2015.
A lack of disclosure and elevated cancer risk are experienced by the LGBTQI community due to reduced access to healthcare and insurance. Researchers suggest training staff in LGBTQI competencies and collecting gender identity and sexual orientation data to improve patient care.
Dr. Vakoc's work reveals an essential connection between epigenetic regulation and oncogenesis, leading to potential new therapeutic approaches for leukemias and other cancers. He will present his lecture at the AACR Annual Meeting 2015.
The National Cancer Institute has renewed its grant to Norris Cotton Cancer Center, solidifying its status as a Comprehensive Cancer Center. The center offers top-notch patient care, cutting-edge research, and innovative treatments.
Dr. William Hahn receives the 39th annual AACR-Rosenthal Memorial Award for his seminal work on cancer initiation, maintenance, and progression. His research provides a foundation for novel therapeutic approaches now being tested in the clinic.
Low is being recognized for his pioneering development of low molecular weight ligands to deliver attached therapeutic and imaging agents selectively into pathologic cells such as cancer cells. This targeted therapeutic approach improves potency and reduces toxicity.
The Global Cancer Project Map is an online resource connecting the global cancer community, enabling access to cancer projects and expertise. The map covers a range of projects, from prevention to palliative care, and aims to reduce health disparities and strengthen human capital in underserved areas.
A blood test identified patients with advanced colorectal cancer who could benefit from a more intensive chemotherapy regimen, reducing hair loss and other side effects. The study found that patients with higher counts of circulating tumour cells in their blood responded better to treatment.
A new study found that cancer patients have variable knowledge about imaging tests, with most wanting basic education about radiation use and understanding how tests differ. Patients also desired information on potential long-term risks and participation in decision-making about medical imaging.
A breakthrough discovery by Queen's University researcher Madhuri Koti has identified biomarkers that can predict the success of chemotherapy in ovarian cancer patients. This finding holds promise for improving treatment options and increasing patient survival rates.
A new study from Brigham and Women's Hospital found that Asian-Americans diagnosed with cancer have significantly lower cancer-specific mortality rates compared to non-Hispanic white patients. The study analyzed data from over 2.5 million patients and broke down the population into eight subgroups, revealing variations in survival rate...
A new study evaluates currently available screening tools for senior cancer patients taking too many medications. It found that a more comprehensive assessment and monitoring plan is needed to improve treatment outcomes.
Researchers developed a non-invasive method to screen for kidney cancer by measuring protein biomarkers in urine, achieving over 95% accuracy. The findings suggest the potential for an easy-to-use screening test, similar to mammograms or colonoscopies, to identify patients with kidney cancer at early stages.
A study published in JAMA found significant discrepancies in diagnoses of atypia and DCIS, highlighting the need for women to seek second opinions. The study involved 115 pathologists and 6,900 breast biopsy interpretations, revealing a concordance rate of 75.3% for invasive carcinoma but only 48% for atypia.
A study by NCCS reveals a new attenuated-dose regimen of sunitinib improves patient quality of life and reduces treatment costs for Asian patients with metastatic renal cell carcinoma. The median overall survival rate increased to 27.4 months, reducing toxicities by 30% compared to the conventional dosing.
A new international study has found a small subset of patients with adrenal cancer respond significantly to the investigational drug linsitinib, paving the way for personalized treatment options. The researchers plan to analyze DNA collected from the study to identify possible markers for response.
Researchers at Georgetown University Medical Center have discovered a cellular pathway that controls organ size, which is also related to cancer cell behavior. High-density cells activated the 'Hippo' molecular pathway, while low-density cells did not engage with it, leading to differences in invasion and growth.
Two new studies present striking findings on depression's influence on cardiovascular health, with depressed patients facing nearly double the risk of dying from heart disease. Additionally, survivors of heart attacks are found to be at higher risk for certain cancers, including lung and bladder cancer.
A genetically engineered immunotoxin called DT2219 has shown safety and clinical effectiveness in a phase I trial for patients with relapsed/refractory B-cell malignancies. Two patients achieved durable objective responses, highlighting the potential of this new treatment approach.
The NCCN Clinical Practice Guidelines in Oncology provide evidence-based recommendations for smoking cessation in patients with cancer. Combining pharmacologic therapy and counseling is the most effective approach, leading to improved cancer treatment effectiveness and decreased recurrence.
Researchers identified germline TP53 gene mutations in 1.3% of patients with early-onset colorectal cancer, comparable to the proportion attributed to APC gene mutations. The findings highlight the need for clinicians to counsel patients undergoing TP53 testing as part of multigene risk assessment.
Patients treated at high-volume facilities for stage III non-small cell lung cancer (NSCLC) have longer overall survival when receiving definitive concurrent chemotherapy and radiation therapy. Studies show improved outcomes for patients treated at these centers, regardless of academic or community status.
Researchers discovered a molecular cause for parvovirus selectivity in cancer cells, revealing the PKCη/Rdx-driven phosphorylation of PDK1. This biomarker predicts therapy effectiveness and identifies cancer cells independent of growth factors.
A new study has identified a group of molecules in prostate-cancer cells that can help distinguish which patients should be treated with radiation therapy if rising PSA levels indicate tumor recurrence. MicroRNA patterns, including miR-4516 and miR-601, may predict patient response to radiation therapy.
A phase II study shows patients with high-risk low-grade gliomas have a 73% three-year overall survival rate when treated with radiation and temozolomide, compared to 54% for historical controls. The findings suggest combining chemotherapy with radiation is the best treatment for these rare tumors.
A family history of prostate cancer in first-degree relatives increases breast cancer risk by 14%, according to a study of 78,171 women. Women with both breast and prostate cancer histories face an almost 2-fold increase in breast cancer risk
Researchers at CWRU found that African-American cancer patients with depression often experience different symptoms than white patients, including irritability and social isolation. These findings suggest that culturally sensitive depression measures are needed to accurately diagnose and treat black cancer patients.
A phase 2 clinical trial found that sunitinib significantly improved progression-free survival in patients with advanced differentiated thyroid cancer. The study showed that 83% of patients benefited from treatment, with either tumor shrinkage or slowed disease progression.
Researchers found that fast food companies fail to promote healthy menu items in their kid's ads, while prioritizing toy premiums. Children recalled toys more than 70% of the time, but noticed food less than half of the time.
A new study identified older white males with advanced bladder cancer as a high-risk group for suicide. Researchers found that these patients have a higher suicide risk compared to those with other genitourinary cancers.
Researchers found that patients who received chemotherapy after bladder cancer surgery had improved overall survival rates compared to those who underwent surgery alone. The study analyzed over 5,600 patients and demonstrated a significant reduction in mortality risk.
A study published in JAMA Oncology found that 10% of CLL patients discontinued ibrutinib therapy due to disease progression. Patients who experienced Richter's transformation or progressive CLL had poorer outcomes and required alternative therapy quickly after discontinuation.
Researchers have identified two urinary biomarkers that can predict bladder cancer-specific survival and guide treatment. The study validated the biomarkers in over 400 clinical samples, showing they are independent predictors of cancer prognosis.
A study published in JAMA Oncology found that patients with advanced cancer perceived a higher level of compassion from physicians when presented with an optimistically framed message about future treatment options. The results suggest the need for extra support and care for delivering bad news while preserving hope.
Researchers deciphered the signaling pathways associated with immortal cells, which work in parallel to suppress terminal differentiation. The discovery enables the use of purified proteins to reduce contamination and accelerate clinical application.
Pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and neutropenia have decreased intensive care consultation rates and lower mortality. The study shows that timely antibiotic delivery can lead to significant reductions in hospitalization and fatalities among pediatric cancer patients.
Researchers from Dartmouth's Norris Cotton Cancer Center have discovered the Cherenkov Effect can be measured to improve radiation therapy. The study found that light emission correlates with dose, making it suitable for narrow beam stereotactic radiation therapy and surface dosimetry applications.
A new TGen study finds targeting stroma surrounding cancer cells can improve treatments and extend patient survival in pancreatic cancer patients. High levels of stroma correlate with poor patient survival, with median survival rates ranging from 9-24 months depending on hyaluronan and collagen levels.
A new study found that cancer patients' preferences for involving family members in treatment decisions differ significantly by ethnic background, marital status, sex, age, and insurance status. Non-English speaking Asian patients and Spanish-speaking Hispanic patients were more likely to share decision-making with their families.
Patients with locally advanced kidney cancer did not experience improved outcomes from adjuvant treatment with sorafenib or sunitinib. The average disease recurrence period was similar between those receiving the drugs and those on placebo, suggesting that these treatments may not be beneficial for this patient group.
A study of 945 patients with intermediate-risk prostate cancer found nearly four-fold higher mortality risk within 15 years compared to low-risk patients. The analysis suggests that active surveillance may not be suitable for all intermediate-risk patients, emphasizing the need for personalized treatment approaches.
A study reveals that hematopoietic stem cells are vulnerable to DNA damage when rapidly dividing under stress conditions. This can lead to premature aging and increase the risk of cancer.
A study by Brigham and Women's Hospital researchers uses epigenomic maps to predict a cancer's cell type of origin, providing new insights into early cancer events. This discovery could help guide treatment decisions for patients with unknown primary sites, which pose significant challenges.
Researchers have found that mutations in the PTEN gene lead to reduced activity and stability of a critical protein, promoting genetic instability and disease. This discovery could pave the way for new treatments for patients with both autism and cancer.
A study found that TERT mRNA levels are highly predictive of aggressive bladder cancers, allowing doctors to recommend targeted treatments and improve patient outcomes. The study also suggests that telomerase reactivation is crucial for the progression of bladder cancers, highlighting a potential target for disease intervention.
Researchers at UT Southwestern Medical Center found that acetate supplements accelerate tumor growth and metastasis in mice. The study suggests that modulating acetate production could be a key to designing therapies for cancer patients.
A survey of 2500 Dutch doctors found that 86% would consider helping a patient to die under certain circumstances. Attitudes towards euthanasia and assisted suicide varied by condition, with most willing to help patients with cancer or other physical diseases, but fewer for those with mental illnesses.
Researchers discovered a key pathway driving tumour growth in bile duct cancer and found that blocking it can prevent cancer cell growth and shrink tumours. The treatment is already being tested in patients with other cancers and shows promise as a potential breakthrough for this devastating disease.
Researchers have identified a new biomarker that can help identify patients who are more likely to respond to certain chemotherapies. MAGE-A3/6 genes contribute to tumor growth by inhibiting AMPK, a protein that controls cellular energy levels and suppresses cancerous tumors.
The 44th annual Barrett-Jackson Scottsdale Auction raised $140,000 for TGen's colon and prostate cancer research. The event featured a '79 Cutlass sold by actress Sharon Stone, previously raising over $600,000 for TGen.